Leukemia Clinical Trials

Showing 3501-3520 of 10,987 trials

Study of CM310 in Patients With Allergic Rhinitis

NCT05908721

This study is a multicenter, single arm, open-label phase II clinical study mainly evaluating the safety of CM310 in patients with allergic rhinitis.

Allergic Rhinitis

Keymed Biosciences Co.Ltd100 participantsStarted Aug 2023

Beijing, China

TERMINATEDPhase 2

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

NCT01318642

This study is a phase 2, multicenter, randomized, double-blind, active placebo-controlled trial of AMG 479 or placebo in combination with gemcitabine as first-line therapy for locally advanced unresectable adenocarinoma of the pancreas. Approximately 150 subjects will be randomized in a 1:1 ratio to AMG 479 and gemcitabine, or gemcitabine and placebo. Randomization will be stratified by ECOG (0 or 1). Gemcitabine will be given on days 1, 8, and 15, followed by AMG 479 on days 1 and 15 of every 28 day cycle. Treatment will continue until radiographic disease progression, unacceptable toxicity, withdrawal of consent, or start of a new anti-cancer therapy.

Adenocarcinoma of the PancreasLocally AdvancedUnresectable

NantBioScience, Inc.10 participantsStarted May 2012

San Francisco, California, United States • Knoxville, Tennessee, United States • Salzburg, Austria +32 more locations

Study of CM310 in Patients With Allergic Rhinitis

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Related Searches

Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

Genetic Variants Associated With the Risk of Gall Stones and Cirrhosis.

TEIPP Immunotherapy in Patients With NSCLC

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

MASA Valve Early Feasibility Study

Minimizing Fall-Related Injury in Older Adults: a Motor Learning Approach

A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia

Natural History of Coronary Atherosclerosis

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients